![Samira Shaikhly](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Samira Shaikhly
Responsable des Ressources Humaines chez
SEPTERNA, INC.
Fortune : 30 253 $ au 31/08/2026
Profil
Samira Shaikhly currently works at Septerna, Inc., as Chief People Officer from 2023.
Ms. Shaikhly also formerly worked at Gilead Sciences, Inc., as Global Head-Human Resources and Ambys Medicines, Inc., as Chief People Officer.
Ms. Shaikhly received her undergraduate degree from the University of San Francisco.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 29/06/2026 | 793 ( 0 % ) | 30 253 $ | 31/08/2026 |
Postes actifs de Samira Shaikhly
| Sociétés | Poste | Début |
|---|---|---|
| SEPTERNA, INC. | Responsable des Ressources Humaines | 01/02/2023 |
Anciens postes connus de Samira Shaikhly
| Sociétés | Poste | Fin |
|---|---|---|
| GILEAD SCIENCES, INC. | Responsable des Ressources Humaines | - |
Ambys Medicines, Inc.
 Ambys Medicines, Inc. Pharmaceuticals: MajorHealth Technology Develops regenerative medicine therapies for serious liver diseases | Responsable des Ressources Humaines | - |
Formation de Samira Shaikhly
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
18
Relations au 1er degré
4
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Gilead Sciences, Inc.
 Gilead Sciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes therapeutic products and treatments for life threatening diseases | Health Technology |
University of San Francisco
 University of San Francisco Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ambys Medicines, Inc.
Ambys Medicines, Inc. Pharmaceuticals: MajorHealth Technology Develops regenerative medicine therapies for serious liver diseases | Health Technology |
Septerna, Inc.
 Septerna, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that discovers and develops G protein-coupled receptor oral small molecule products for the treatment of hypoparathyroidism | Health Technology |
